Not yet a member?
Dr. Laskin and I have had a bit of a back and forth discussion about the names to use for our treatments in lung cancer. The preference for our clinical meetings is to use the scientific, generic names for drugs — erlotinib instead of tarceva, pemetrexed instead of alimta, etc. [...]
10 Comments